Amount after tax of reclassification adjustment from accumulated other comprehensive income for translation gain (loss) realized upon the sale or liquidation of an investment in a foreign entity and foreign currency hedges that are designated and qualified as hedging instruments for hedges of the foreign currency exposure of a net investment in a foreign operation.

+ References+ Details

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References+ Details

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 5) (USD $) In Thousands, unless otherwise specified	12 Months Ended			1 Months Ended	3 Months Ended
	Dec. 28, 2013	Dec. 29, 2012	Dec. 31, 2011	Feb. 28, 2013 Manganese Materials Company Pty. Ltd.	Mar. 30, 2013 Manganese Materials Company Pty. Ltd.
Equity Method Investments
Proceeds from sale of business				$ 29,250
Amount recognized in currency translation adjustments previously recorded as part of accumulated other comprehensive income	(5,194)		(1,446)	5,194
Deferred tax benefits associated with sale of business					3,200
Research and Development
Research and development expenses	$ 10,200	$ 7,100	$ 6,200